Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Eur J Vasc Endovasc Surg. 2012 Jul;44(1):40-4. doi: 10.1016/j.ejvs.2012.04.022. Epub 2012 May 22.
Sac growth after endovascular aneurysm repair (EVAR) is an important finding, which may influence prognosis. In case of a type II endoleak or endotension, clipping of side branches and subsequent sac fenestration has been presented as a therapeutic alternative. The long-term clinical efficacy of this procedure is unknown.
The study included eight patients who underwent laparoscopic aortic collateral clipping and sac fenestration for enlarging aneurysms following EVAR. Secondary interventions and clinical outcome were retrieved from hospital records. Sac behaviour was evaluated measuring volumes on periodical computed tomography angiography (CTA) imaging using dedicated software.
Follow-up had a median length of 6.6 (range 0.6-8.6) years. During this time, only three patients successfully achieved durable aneurysm shrinkage (n = 2) or stability (n = 1). The remaining patients suffered persistent (n = 2) or recurrent sac growth (n = 3), all regarded as failure of fenestration. A total of six additional interventions were performed, comprising open conversion (n = 2), relining (n = 1) and implantation of iliac extensions (n = 3). All additional interventions were successful at arresting further sac growth during the remainder of follow-up.
Despite being a less invasive alternative to conversion and open repair, the long-term outcome of sac fenestration is unpredictable and additional major procedures were often necessary to arrest sac growth.
血管内动脉瘤修复(EVAR)后瘤体增大是一个重要发现,可能影响预后。在存在 II 型内漏或内张力的情况下,夹闭侧支血管并随后进行瘤囊开窗已被提出作为一种治疗选择。该手术的长期临床疗效尚不清楚。
本研究纳入了 8 例因 EVAR 后瘤体增大而行腹腔镜主动脉侧支血管夹闭和瘤囊开窗术的患者。从病历中检索到次要干预措施和临床结果。通过专用软件在定期 CT 血管造影(CTA)成像上测量瘤体容积,评估瘤体行为。
随访中位数长度为 6.6 年(范围 0.6-8.6 年)。在此期间,仅 3 例患者成功实现了持久的瘤体缩小(n = 2)或稳定(n = 1)。其余患者出现持续(n = 2)或复发性瘤体增大(n = 3),均被认为是开窗失败。总共进行了 6 次额外的干预,包括开放转换(n = 2)、重新衬里(n = 1)和植入髂支(n = 3)。在随访的剩余时间里,所有额外的干预措施都成功地阻止了瘤体进一步增大。
尽管作为转换和开放修复的一种微创替代方法,但开窗术的长期结果不可预测,通常需要进行额外的主要手术来阻止瘤体增大。